Lucid Group Names Eric Muller as Chief Executive Officer to Lead Next Phase of Growth
August 19, 2026 |
Rick Sannem, outgoing CEO, transitions to Strategic Advisor to the Board
LONDON & PHILADELPHIA, 19 August 2026 – Lucid Group, a leader in healthcare communications and commercialisation, today announced that Eric Muller has joined the agency as Chief Executive Officer. He will succeed CEO, and original DiD Agency founder Rick Sannem, who will transition to Strategic Advisor to the Board.
This transition comes as Lucid Group continues to grow its global footprint and reflects a deliberate step to assemble the talent to drive the company’s next phase of growth, while strengthening its ability to translate complex science into real-world impact.
“Lucid works across the full arc of product commercialisation, from the earliest stages of clinical development to market launch and on through to loss of exclusivity. Eric understands how hard it can be for great science to break through but also how to commercialise healthcare at scale,” said Dr Rod MacKenzie, CMG, Chair, Lucid Group Board. “Our Board is grateful for Rick’s vision and entrepreneurial stewardship that built Lucid’s culture of delivering client success and pleased that he will continue to support us as we enter our next chapter.”
For more than 20 years, Lucid Group has built its reputation on deep client relationships and a shared mission to transform lives by ensuring innovative medicine doesn’t stop at approval, but it reaches the patients who need it most. As an independent firm, Lucid delivers its range of services as a single team, which means the senior people who win an engagement stay on it, from pitch through delivery.
“Healthcare is entering a new era, driven by extraordinary advances in science, data, and technology. Clients increasingly need a partner that turns complexity into clarity and impact by bringing together scientific expertise, creativity, and strategy, along with the power of data and AI. As data multiplies and development accelerates, knowing which evidence matters and what creative output will persuade is the part that becomes critical,” said Eric Muller, Chief Executive Officer, Lucid Group. “That is the future of healthcare marketing, and it is where Lucid is positioned to lead. I am a builder at heart, and I came to Lucid to build a business that helps clinicians, patients, and caregivers make better decisions about the things that matter most.”
Eric is a highly experienced executive who has operated both commercially and in senior leadership positions across global healthcare commercialisation for more than 25 years. Most recently, Eric was Group President and Chief Operating Officer of Publicis Health and previously held roles including President of Digitas Health. He began his career at Grey Advertising in New York.
His immediate priorities centre on expanding talent, client partnerships as well as data and technological capabilities. The company aims to further attract the best people in the industry, while being the partner they trust to succeed and building the data and AI capability that enables Lucid’s science, strategy, and creative to travel further.
“Years ago, we made a deliberate decision to build an independent business that brings specialised commercialisation services together under one roof to best serve healthcare and pharma clients and that’s exactly what Lucid has become,” said Rick Sannem, Strategic Advisor to Lucid’s Board of Directors. “I’m proud of the culture and standard of excellence we’ve built, and Eric’s track record as a hands-on, transformative leader makes him the right person to lead Lucid into its next chapter of growth.”
About Lucid Group
Lucid Group, a global leader in healthcare communications and commercialisation, is driven by a mission to transform lives by bridging the gap between scientific discovery and patient impact. For life sciences organisations navigating their highest-stakes decisions, Lucid doesn’t just communicate science but ensures clients leave a lasting impact on the market and the patients they serve. Lucid brings together experts across Strategy Consulting, Scientific and Medical Communications, and Commercial Communications, fusing scientific rigour, strategic foresight, commercial ingenuity, creative storytelling, and deep human insight into an integrated force, powered by real-world evidence. This unique approach allows Lucid to uncover the deep-seated insight that governs stakeholder behaviour and anchors bold, behaviour-changing ideas, executed at key moments and accelerated by AI and technology. To learn more about Lucid Group, visit www.wearelucidgroup.com and LinkedIn.
Media Contacts:
Chris Dougherty
Elyse Cole
This content was provided by Lucid Group Communications Limited
Company Details
Latest Content from Lucid Group Communications Limited
Tajinder’s #LucidLife
Medical writers are like gold dust, so when we find talented writers with great experience,we offer a tailor-made package.Are you a world-class medical writer?Do you like the look of Tajinder’s…
Fiona’s #LucidLife
Meet Fiona, a medical writer.She told us what she wanted, and we did the rest.We believe that medical writers are like gold dust; so when we find talent, we do…
Lucid Group: What medical communications means to us
Katherine Duxbury, Scientific Director at Lucid, explains what medical communications means to Lucid: What we do, how we do it and what makes us different.
Lucid make the shortlist in all of the four categories they entered for the PMEA programme 2016
The PMEA programme rewards responsible customer-centric business practices that ensure treatments and advice provide patients with meaningful outcomes. The awards have been specifically designed to recognise and commend excellence, best…
Lucid bolsters its senior leadership team
Lucid Group has had a successful summer attracting top talent to its senior leadership team with the appointment of Shula Sarner (Executive Scientific Director) and Tanya Goodyear (Division Director, Immunology).
IBD Oxford MasterClass 2016 harnesses the chemistry between science and clinical practice
Leading Edge, part of the Lucid Group, delivered another successful Oxford MasterClass this year, which attracted over 260 delegates and 60 international inflammatory bowel disease (IBD) faculty, representing Europe, Asia, Australasia…
Lucid Group becomes a sponsor of MedComms Networking
To help Lucid access the valuable medical communications professional network they have become a sponsor of MedComms Networking, headed by Peter Llewellyn. Jan Steele (Co-founder and COO of Lucid Group)…
Tenth Lucid Academy module delivered – nurturing talent and driving excellence
Celebrating the success of the Lucid Academy
Lucid launch new recruitment campaign to attract top talent in medical writing
We will offer talented writers an exclusive, tailor-made package to suit their individual needs and desires. We want you to define the framework of your Lucid Life contract – from…
Knowing your audience is key to successful medical education
Lucid Group understands that the goals of medical education are to disseminate best practice and advance patient outcomes. Our approach to meeting these goals centres on our appreciation of both…